I don't bash anything. I point out what is written in the bible and quote from it. It is not what I say that is a problem, just what is written. And you miss the point of the studies. It is not the government telling us anything, but the research, double blind experiments, etc, that shows that Ivermectin is not particularly effective in treating Covid. Stories of recoveries are not enough because most people recover regardless. It's not a 100% mortality rate, if you haven't noticed
OK, I'll forget my remark about the test for prophets.
Government officials absolutely made false pronouncements about Covid-19 vaccines, treatments, and prevention. Government restrictions, mandates, and lockdowns did not stop the spread and the vaccines did not work.
What, you expect to get fact, accuracy and truth from politicians? You think they are trustworthy?
The average politician is more concerned with their own image and appearing to do something for the people than actual truth.
Originally Posted by Hastings
Government and especially the big medical journals and the pharmaceutical companies made it very unpleasant for physicians to prescribe Ivermectin. They leaned on insurance companies not to pay for Ivermectin or Hydroxy. Walmart and the other big pharmacies refused to fill the prescriptions. You reckon the government and "science" wouldn't lie about the evidence that these drugs work???
Big pharma can be as bad as politicians when it comes to protecting their industry and their bottom line.
Originally Posted by Hastings
If most of Sub Saharan Africa and India along with millions in the U.S. and Australia successfully used veterinary Ivermectin with good results do you think there would be any "scientific" effort to study those results?
What comes out of sub Saharan Africa is not something you should be basing your beliefs on.
Originally Posted by Hastings
Do you think the survival rate among the Amish in Wayne county Ohio will be studied or do you think some scientist might check with them and see if they had any use of "horse wormer". No, there will be no such investigations and there will be no admissions of the lies, mistakes, failures, and over reactions of science and government all of which caused harm and left very little evidence of benefit.
Once more, rigorous double blind experiments do not show a significant benefit to taking Ivermectin for Covid.
Again;
What do the studies show?
Question Does ivermectin, with a maximum targeted dose of 600 μg/kg daily for 6 days, compared with placebo, shorten symptom duration among adult (≥30 years) outpatients with symptomatic mild to moderate COVID-19?
Findings In this double-blind, randomized, placebo-controlled platform trial including 1206 US adults with COVID-19 during February 2022 to July 2022, the median time to sustained recovery was 11 days in the ivermectin group and 11 days in the placebo group. In this largely vaccinated (84%) population, the posterior probability that ivermectin reduced symptom duration by more than 1 day was less than 0.1%.
Meaning These findings do not support the use of ivermectin among outpatients with COVID-19.
Abstract
Importance It is unknown whether ivermectin, with a maximum targeted dose of 600 μg/kg, shortens symptom duration or prevents hospitalization among outpatients with mild to moderate COVID-19.
Objective To evaluate the effectiveness of ivermectin at a maximum targeted dose of 600 μg/kg daily for 6 days, compared with placebo, for the treatment of early mild to moderate COVID-19.
Design, Setting, and Participants The ongoing Accelerating COVID-19 Therapeutic Interventions and Vaccines 6 (ACTIV-6) platform randomized clinical trial was designed to evaluate repurposed therapies among outpatients with mild to moderate COVID-19. A total of 1206 participants older than 30 years with confirmed COVID-19 experiencing at least 2 symptoms of acute infection for less than or equal to 7 days were enrolled at 93 sites in the US from February 16, 2022, through July 22, 2022, with follow-up data through November 10, 2022.
Interventions Participants were randomly assigned to receive ivermectin, with a maximum targeted dose of 600 μg/kg (n = 602) daily, or placebo (n = 604) for 6 days.
Main Outcomes and Measures The primary outcome was time to sustained recovery, defined as at least 3 consecutive days without symptoms. The 7 secondary outcomes included a composite of hospitalization, death, or urgent/emergent care utilization by day 28.
Results Among 1206 randomized participants who received study medication or placebo, the median (IQR) age was 48 (38-58) years, 713 (59.1%) were women, and 1008 (83.5%) reported receiving at least 2 SARS-CoV-2 vaccine doses. The median (IQR) time to sustained recovery was 11 (11-12) days in the ivermectin group and 11 (11-12) days in the placebo group. The hazard ratio (posterior probability of benefit) for improvement in time to recovery was 1.02 (95% credible interval, 0.92-1.13; P = .68). Among those receiving ivermectin, 34 (5.7%) were hospitalized, died, or had urgent or emergency care visits compared with 36 (6.0%) receiving placebo (hazard ratio, 1.0 [95% credible interval, 0.6-1.5]; P = .53). In the ivermectin group, 1 participant died and 4 were hospitalized (0.8%); 2 participants (0.3%) were hospitalized in the placebo group and there were no deaths. Adverse events were uncommon in both groups.
Conclusions and Relevance Among outpatients with mild to moderate COVID-19, treatment with ivermectin, with a maximum targeted dose of 600 μg/kg daily for 6 days, compared with placebo did not improve time to sustained recovery. These findings do not support the use of ivermectin in patients with mild to moderate COVID-19.
